DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, presenting promising enhancements throughout different medical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, far more dependable option for therapeutic use,